Literature DB >> 31652356

The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.

Victoria K Berger1,2, Mary E Norton1,2, Teresa N Sparks1,2, Monica Flessel3, Rebecca J Baer4, Robert J Currier5.   

Abstract

Entities:  

Year:  2019        PMID： 31652356      PMCID： PMC7002253          DOI： 10.1002/pd.5583

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  35 in total

1.  Detection Rates for Aneuploidy by First-Trimester and Sequential Screening.

Authors:  Rebecca J Baer; Monica C Flessel; Laura L Jelliffe-Pawlowski; Sara Goldman; Louanne Hudgins; Andrew D Hull; Mary E Norton; Robert J Currier
Journal:  Obstet Gynecol       Date:  2015-10       Impact factor: 7.661

2.  Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation.

Authors:  Po-Jen Cheng; Shuenn-Dhy Chang; Sheng-Wen Shaw; Yung-Kuei Soong
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

3.  ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

Review 4.  First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness.

Authors:  C Ngo; G Viot; M C Aubry; V Tsatsaris; G Grange; D Cabrol; E Pannier
Journal:  Ultrasound Obstet Gynecol       Date:  2007-08       Impact factor: 7.299

Review 5.  Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis.

Authors:  M Grande; F A R Jansen; Y J Blumenfeld; A Fisher; A O Odibo; M C Haak; A Borrell
Journal:  Ultrasound Obstet Gynecol       Date:  2015-12       Impact factor: 7.299

6.  Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center.

Authors:  Christina M L Alamillo; David Krantz; Mark Evans; Morris Fiddler; Eugene Pergament
Journal:  Prenat Diagn       Date:  2013-01-27       Impact factor: 3.050

7.  What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?

Authors:  Emily S Reiff; Sarah E Little; Lori Dobson; Louise Wilkins-Haug; Bryann Bromley
Journal:  Prenat Diagn       Date:  2016-02-05       Impact factor: 3.050

8.  Risk of selected structural abnormalities in infants after increased nuchal translucency measurement.

Authors:  Rebecca J Baer; Mary E Norton; Gary M Shaw; Monica C Flessel; Sara Goldman; Robert J Currier; Laura L Jelliffe-Pawlowski
Journal:  Am J Obstet Gynecol       Date:  2014-06-17       Impact factor: 8.661

9.  First-trimester screening for trisomies 21 and 18.

Authors:  Ronald Wapner; Elizabeth Thom; Joe Leigh Simpson; Eugene Pergament; Richard Silver; Karen Filkins; Lawrence Platt; Maurice Mahoney; Anthony Johnson; W Allen Hogge; R Douglas Wilson; Patrick Mohide; Douglas Hershey; David Krantz; Julia Zachary; Rosalinde Snijders; Naomi Greene; Rudy Sabbagha; Scott MacGregor; Lyndon Hill; Alain Gagnon; Terrence Hallahan; Laird Jackson
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

10.  Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort.

Authors:  Marianne Christiansen; Charlotte K Ekelund; Olav Bjørn Petersen; Jon Hyett; Nathan Eastwood; Susan Ball; Ann Tabor; Ida Vogel
Journal:  Prenat Diagn       Date:  2015-11-19       Impact factor: 3.050
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.